Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Safety and efficacy of low-intensity chemotherapy combined with sequential blinatumomab and inotuzumab ozogamicin immunotherapy in newly diagnosed B-ALL patients unfit/fit-declined for intensive chemotherapy: A prospective, open-label, single-arm Phase II trial in progress

Shenhao Liu, Chongsheng Qian, Haiping Dai, Lan Dai, Yanjun Wu, Zhen Yao, Zheng Li, Wenjie Gong, Aining Sun, Depei Wu, Shengli Xue

Blood (2025) 146 (Supplement 1): 3358.

https://doi.org/10.1182/blood-2025-3358

Published: 2025

Journal Articles

Auto-HSCT combined with blinatumomab as an allo-HSCT-sparing strategy in newly diagnosed B-ALL: Phase II trial results

Zihao Wang, Chongsheng Qian, Zhen Yao, Zheng Li, Wenjie Gong, Haiping Dai, Yanjun Wu, Kai-Wen Tan, Fangtong Liu, Chao-Ling Wan, Depei Wu, Shengli Xue

Blood (2025) 146 (Supplement 1): 3349.

https://doi.org/10.1182/blood-2025-3349

Published: 2025

Journal Articles

Selinexor and Chidamide in Patients with Relapsed/Refractory Acute Myeloid Leukemia Exposed to Venetoclax: A Single-Arm, Phase 2 Study

Jian Zhang, Baoquan Song, Yin Liu, Yanjun Wu, De-Pei Wu, Huiying Qiu

Blood (2023) 142 (Supplement 1): 5950.

https://doi.org/10.1182/blood-2023-185770

Published: 2023